RTW INVESTMENTS, LP Q2 2021 Filing
Filed August 13, 2021
Portfolio Value
$6.6B
Holdings
113
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTROCKET PHARMACEUTICALS INC | 14,990,286 | $663.9B | 10018.37% | |
| 2 | SPYSPDR S&P 500 ETF TR | 996,255 | $426.5B | 6435.12% | |
| 3 | ALNYALNYLAM PHARMACEUTICALS INC | 1,683,362 | $285.4B | 4306.06% | |
| 4 | —DICERNA PHARMACEUTICALS INC | 7,521,859 | $280.7B | 4235.93% | |
| 5 | VCELVERICEL CORP | 4,517,570 | $237.2B | 3578.86% | |
| 6 | MRTXEURMIRATI THERAPEUTICS INC | 1,457,532 | $235.4B | 3552.65% | |
| 7 | ILMNILLUMINA INC | 482,791 | $228.5B | 3447.43% | |
| 8 | PTCTPTC THERAPEUTICS INC | 5,293,966 | $223.8B | 3376.72% | |
| 9 | ESTAESTABLISHMENT LABS HLDGS INC | 2,319,138 | $202.6B | 3056.48% | |
| 10 | 3M4MASIMO CORP | 826,210 | $200.3B | 3022.70% | |
| 11 | NTRANATERA INC | 1,712,234 | $194.4B | 2933.29% | |
| 12 | PTGXPROTAGONIST THERAPEUTICS INC | 3,507,390 | $157.4B | 2375.30% | |
| 13 | TXG10X GENOMICS INC | 734,481 | $143.8B | 2170.29% | |
| 14 | TCE2CELLDEX THERAPEUTICS INC NEW | 3,908,947 | $130.7B | 1972.45% | |
| 15 | DMTKQDERMTECH INC | 3,118,665 | $129.6B | 1956.28% | |
| 16 | GMEDGLOBUS MED INC | 1,670,811 | $129.5B | 1954.69% | |
| 17 | AXNX*AXONICS INC | 1,943,864 | $123.3B | 1859.96% | |
| 18 | STOKSTOKE THERAPEUTICS INC | 3,644,248 | $122.7B | 1850.98% | |
| 19 | GHGUARDANT HEALTH INC | 918,253 | $114.0B | 1720.80% | |
| 20 | QDELUSDQUIDEL CORP | 878,533 | $112.6B | 1698.47% | |
| 21 | TNDMTANDEM DIABETES CARE INC | 1,147,408 | $111.8B | 1686.40% | |
| 22 | AXSMAXSOME THERAPEUTICS INC | 1,616,497 | $109.0B | 1645.52% | |
| 23 | RNAAVIDITY BIOSCIENCES INC | 3,995,000 | $98.7B | 1489.60% | |
| 24 | EPIEURESSA PHARMA INC | 3,053,919 | $87.3B | 1316.58% | |
| 25 | CCCCC4 THERAPEUTICS INC | 2,149,228 | $81.3B | 1227.20% | |
| 26 | —PROMETHEUS BIOSCIENCES INC | 3,264,031 | $76.0B | 1146.65% | |
| 27 | IDYAIDEAYA BIOSCIENCES INC | 3,266,255 | $68.6B | 1034.54% | |
| 28 | MGNXMACROGENICS INC | 2,546,925 | $68.4B | 1032.29% | |
| 29 | RGNXREGENXBIO INC | 1,757,743 | $68.3B | 1030.45% | |
| 30 | AGENEURAGENUS INC | 11,437,238 | $62.8B | 947.48% | |
| 31 | CSTLCASTLE BIOSCIENCES INC | 799,009 | $58.6B | 884.12% | |
| 32 | TARSTARSUS PHARMACEUTICALS INC | 2,013,601 | $58.4B | 880.55% | |
| 33 | NSTGEURNANOSTRING TECHNOLOGIES INC | 804,029 | $52.1B | 786.07% | |
| 34 | LUNGPULMONX CORP | 1,129,600 | $49.8B | 752.04% | |
| 35 | RLMDRELMADA THERAPEUTICS INC | 1,538,026 | $49.2B | 742.90% | |
| 36 | —LANDOS BIOPHARMA INC | 4,275,722 | $48.5B | 731.20% | |
| 37 | IMCRIMMUNOCORE HLDGS PLC | 1,245,532 | $47.9B | 722.62% | |
| 38 | 5E7ITEOS THERAPEUTICS INC | 1,716,585 | $44.0B | 664.40% | |
| 39 | PRQRPROQR THRAPEUTICS N V | 6,443,113 | $43.4B | 655.30% | |
| 40 | —OLINK HLDG AB | 1,248,188 | $43.0B | 648.30% | |
| 41 | GHRSGH RESEARCH PLC | 2,168,957 | $42.7B | 643.74% | |
| 42 | OPHTEURIVERIC BIO INC | 6,722,624 | $42.4B | 640.11% | |
| 43 | CYTKCYTOKINETICS INC | 2,000,000 | $39.6B | 597.25% | |
| 44 | AVDLAVADEL PHARMACEUTICALS PLC | 5,741,939 | $38.6B | 583.11% | |
| 45 | OMGBPOUTSET MED INC | 737,152 | $36.8B | 555.95% | |
| 46 | —GENETRON HLDGS LTD | 1,818,162 | $36.6B | 552.56% | |
| 47 | CUTREURCUTERA INC | 720,817 | $35.3B | 533.30% | |
| 48 | APYXAPYX MEDICAL CORPORATION | 3,391,279 | $35.0B | 527.60% | |
| 49 | MDXGMIMEDX GROUP INC | 2,700,320 | $33.8B | 509.75% | |
| 50 | FULCFULCRUM THERAPEUTICS INC | 3,205,291 | $33.6B | 506.88% | |
| 51 | OYSTOYSTER PT PHARMA INC | 1,861,209 | $32.0B | 482.78% | |
| 52 | JNJJOHNSON & JOHNSON | 170,542 | $28.1B | 423.95% | |
| 53 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 7,357,917 | $25.8B | 388.61% | |
| 54 | GLUEMONTE ROSA THERAPEUTICS INC | 1,214,572 | $25.2B | 380.68% | |
| 55 | MISTMILESTONE PHARMACEUTICALS IN | 4,315,102 | $23.7B | 358.12% | |
| 56 | TELATELA BIO INC | 1,392,434 | $22.4B | 338.49% | |
| 57 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 4,206,765 | $20.5B | 309.14% | |
| 58 | TREURTRILLIUM THERAPEUTICS INC | 2,091,389 | $20.3B | 306.11% | |
| 59 | —ATHIRA PHARMA INC | 1,906,557 | $19.5B | 294.60% | |
| 60 | I9DNARBUTUS BIOPHARMA CORP | 5,978,355 | $18.1B | 273.34% | |
| 61 | PMVPPMV PHARMACEUTICALS INC | 484,133 | $16.5B | 249.55% | |
| 62 | BWAYBRAINSWAY LTD | 1,602,181 | $16.3B | 246.60% | |
| 63 | BLUBELLUS HEALTH INC NEW | 4,968,017 | $15.4B | 233.00% | |
| 64 | NEONEOGENOMICS INC | 311,111 | $13.1B | 198.26% | |
| 65 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 500,000 | $12.8B | 193.30% | |
| 66 | XGNEXAGEN INC | 821,414 | $12.3B | 185.80% | |
| 67 | BMEABIOMEA FUSION INC | 830,794 | $12.3B | 185.15% | |
| 68 | INMDINMODE LTD | 124,999 | $11.8B | 178.59% | |
| 69 | BLIUSDBERKELEY LTS INC | 257,546 | $11.5B | 174.15% | |
| 70 | IMUXIMMUNIC INC | 920,814 | $11.3B | 170.35% | |
| 71 | —ASLAN PHARMACEUTICALS LTD | 3,250,000 | $10.7B | 161.84% | |
| 72 | NAUTNAUTILUS BIOTECHNOLOGY INC | 1,100,000 | $10.4B | 156.68% | |
| 73 | —LA JOLLA PHARMACEUTICAL CO | 2,327,903 | $10.0B | 150.34% | |
| 74 | —LIFESCI ACQUISITION II CORP | 975,000 | $9.8B | 147.12% | |
| 75 | —VINCERX PHARMA INC | 749,999 | $9.7B | 147.00% | |
| 76 | ARGXARGENX SE | 31,752 | $9.6B | 144.26% | |
| 77 | CTMXCYTOMX THERAPEUTICS INC | 1,400,939 | $8.9B | 133.82% | |
| 78 | CNTBCONNECT BIOPHARMA HLDGS LTD | 450,000 | $8.8B | 132.62% | |
| 79 | —CHARDAN HEALTHCR ACQSTN 2 CO | 837,540 | $8.3B | 125.23% | |
| 80 | MLTXHELIX ACQUISITION CORP | 750,000 | $7.8B | 117.14% | |
| 81 | AFIBACUTUS MED INC | 451,834 | $7.7B | 115.77% | |
| 82 | —BCTG ACQUISITION CORP | 600,000 | $6.8B | 103.03% | |
| 83 | —RESEARCH ALLIANCE CORP II | 637,000 | $6.5B | 97.46% | |
| 84 | —BCLS ACQUISITION CORP | 612,500 | $6.5B | 97.33% | |
| 85 | —ITAMAR MED LTD | 268,609 | $6.3B | 95.46% | |
| 86 | APVOAPTEVO THERAPEUTICS INC | 281,402 | $6.3B | 95.25% | |
| 87 | RCELAVITA MEDICAL INC | 280,000 | $5.7B | 86.71% | |
| 88 | —ARYA SCIENCES ACQU CORP IV | 500,000 | $5.4B | 80.88% | |
| 89 | —THERAPEUTICS ACQUISITION COR | 490,000 | $5.0B | 75.96% | |
| 90 | —SUMMIT HEALTHCRE ACQUISTN CO | 500,000 | $5.0B | 75.52% | |
| 91 | SRRKSCHOLAR ROCK HLDG CORP | 161,612 | $4.7B | 70.48% | |
| 92 | DNAYCODEX DNA INC | 200,000 | $4.4B | 66.39% | |
| 93 | CVRXCVRX INC | 150,000 | $4.2B | 63.38% | |
| 94 | IMTXIMMATICS N.V | 350,000 | $4.1B | 61.32% | |
| 95 | —5 01 ACQUISITION CORP | 392,000 | $3.9B | 58.97% | |
| 96 | —CHARDAN HEALTHCR ACQSTN 2 CO | 350,000 | $3.6B | 54.99% | |
| 97 | —MIROMATRIX MED INC | 280,000 | $3.3B | 49.22% | |
| 98 | PSNLPERSONALIS INC | 127,501 | $3.2B | 48.68% | |
| 99 | MRVIMARAVAI LIFESCIENCES HLDGS I | 70,000 | $2.9B | 44.08% | |
| 100 | —MEDICUS SCIENCES ACQUISITION | 300,000 | $2.9B | 43.68% |
Page 1 of 2Next